Trial intelligence / Profile preview

PK Effect of Clarithromycin on Linezolid in MDR/XDR-TB

NCT01521364Phase 4Completed

Sponsor
University Medical Center Groningen
Start
Dec 2011
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clarithromycin in Tuberculosis (TB), sponsored by University Medical Center Groningen. Started Dec 2011; status: completed.

02

Drugs

clarithromycin
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NCT01521364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01521364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call